BB Biotech Stock Forward View - Double Exponential Smoothing
| BION Stock | CHF 45.40 0.65 1.45% |
BB Biotech's Double Exponential Smoothing reference data is presented on this page, derived from the application of the forecasting model to historical closing prices. Projected values and accuracy measures are included for reference.
The Double Exponential Smoothing forecasted value of BB Biotech AG on the next trading day is expected to be 45.36 with a mean absolute deviation of 0.69 and the sum of the absolute errors of 40.46.When BB Biotech AG prices exhibit either an increasing or decreasing trend over time, simple exponential smoothing forecasts tend to lag behind observations. Double exponential smoothing is designed to address this type of data series by taking into account any BB Biotech AG trend in the prices. So in double exponential smoothing past observations are given exponentially smaller weights as the observations get older. In other words, recent BB Biotech observations are given relatively more weight in forecasting than the older observations. The Double Exponential Smoothing reference information for BB Biotech is based on available price data and is intended for informational purposes. Double Exponential Smoothing Price Forecast For the 23rd of March
Given 90 days horizon, the Double Exponential Smoothing forecasted value of BB Biotech AG on the next trading day is expected to be 45.36 with a mean absolute deviation of 0.69 , mean absolute percentage error of 0.81 , and the sum of the absolute errors of 40.46 .Please note that although there have been many attempts to predict BION Stock prices using its time series forecasting, we generally do not suggest using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that BB Biotech's next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).
Stock Forecast Pattern
| Backtest BB Biotech | BB Biotech Price Prediction | Research Analysis |
Forecasted Value
For the next trading day, Macroaxis evaluates BB Biotech's predictive range by looking for statistically meaningful downside and upside boundaries. The projected forecast band currently runs from roughly 43.56 on the downside to about 47.17 on the upside.
Model Predictive Factors
The below table displays some essential indicators generated by the model showing the Double Exponential Smoothing forecasting method's relative quality and the estimations of the prediction error of BB Biotech stock data series using in forecasting. Note that when a statistical model is used to represent BB Biotech stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.| AIC | Akaike Information Criteria | Huge |
| Bias | Arithmetic mean of the errors | 0.1587 |
| MAD | Mean absolute deviation | 0.6858 |
| MAPE | Mean absolute percentage error | 0.0148 |
| SAE | Sum of the absolute errors | 40.4637 |
Other Forecasting Options for BB Biotech
For any investor considering BION, BB Biotech's price movement is the central factor in determining investment viability. The noise present in BION Stock price charts can distort investment decisions if not properly addressed.BB Biotech Related Equities
The following equities are related to BB Biotech within the Health Care space and can be used for peer comparison, relative valuation, or portfolio diversification. Comparing BB Biotech against peers on metrics such as P/E, margins, and return on equity helps contextualize its positioning and identify relative strengths or weaknesses.
| Risk & Return | Correlation |
BB Biotech Market Strength Events
Market strength indicators for BB Biotech stock help investors evaluate the security's behavior relative to ongoing market conditions. These tools support better market timing and help identify entry and exit signals for BB Biotech AG.
BB Biotech Risk Indicators
The analysis of BB Biotech's basic risk indicators is a key input for accurate price forecasting and sound investment decisions. Understanding the risk in BB Biotech's investment allows investors to make informed choices about accepting or mitigating that exposure.
| Mean Deviation | 1.36 | |||
| Semi Deviation | 1.76 | |||
| Standard Deviation | 1.76 | |||
| Variance | 3.09 | |||
| Downside Variance | 3.56 | |||
| Semi Variance | 3.11 | |||
| Expected Short fall | -1.47 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for BB Biotech
The amount of media and story coverage tied to BB Biotech AG can signal where market attention is concentrating at the moment. A disciplined read of coverage separates durable relevance from temporary noise.
Other Macroaxis Stories
Macroaxis publishes story content for a diverse readership that includes finance students, independent investors, money managers, and market-focused operating teams. What connects that audience is a focus on building stronger portfolios through better research, risk awareness, and comparative analysis.
Story Categories
Currently Trending Categories
BB Biotech Short Properties
Reviewing short-oriented indicators for BB Biotech AG is useful because long and short participants often create very different signals for timing and volatility. The practical goal is to identify when the balance between long and short participation may be changing the quality of the setup.
| Common Stock Shares Outstanding | 55.1 M | |
| Cash And Short Term Investments | 99.4 M |
Additional Tools for BION Stock Analysis
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments |